Local immune responses and systemic cytokine responses in zoster: Relationship to the development of postherpetic neuralgia

Clinical and Experimental Immunology

Volumn 131, Issue 2, 2003, Pages 318-323

  Zak Prelich, M ^a   McKenzie, R C ^b   Sysa Jedrzejowska, A ^a   Norval, Mary ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cutaneous immune responses; Cytokines; Lymphocytes; Postherpetic neuralgia; Zoster

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTIBODIES, VIRAL; ANTIGENS, CD3; ANTIGENS, CD56; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MALE; MIDDLE AGED; NEURALGIA; SKIN; SUBSTANCE P; T-LYMPHOCYTE SUBSETS;

EID: 0037320276     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02061.x     Document Type: Article

References (22)

1. McCrary ML, Severson J, Tyring SK. Varicella zoster virus. J Am Acad Dermatol 1999; 41:1-14.
2. LaGuardia JJ, Gilden DH. Varicella-zoster virus: a re-emerging infection. J Invest Dermatol Symp Proc 2001; 6:183-7.
3. Arvin AM, Koropchak CM, Williams BR, Grumet FC, Foung SK. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection. J Infect Dis 1986; 154:422-9.
4. Jenkins DE, Redman RL, Meng Lam E, Liu C, Lin I, Arvin AM. Interleukin (IL)-10, IL-12, and interferon-γ production in primary and memory immune responses to varicella-zoster virus. J Infect Dis 1998; 178:940-8.
5. Wilson A, Sharp M, Koropchak CM, Ting SF, Arvin AM. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992; 165:119-26.
6. Zhang Y, Cosyns M, Levin MJ, Hayward AR. Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures. Clin Exp Immunol 1994; 98:128-33.
7. Webster A, Grint P, Brenner MK, Prentice HG, Griffiths PD. Titration of IgG antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster. J Med Virol 1989; 27:117-9.
8. Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA. Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ 2000; 321:794-6.
9. Decroix J, Partsch H, Gonzalez R et al. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. J Eur Acad Dermatol Venereol 2000; 14:23-33.
10. Mahalingam R, Wellish M, Brucklier J, Gilden DH. Persistence of varicella-zoster virus DNA in elderly patients with postherpetic neuralgia. J Neurovirol 1995; 1:130-3.
11. Lambert RW, Granstein RD. Neuropeptides and Langerhans cells. Exp Dermatol 1998; 7:73-80.
12. Szepietowski JC, Walker C, McKenna DB, Hunter JAA, McKenzie RC. Leukaemia inhibitory factor (LIF) and interleukin (IL)-8 expression in non-melanoma skin cancers. Clin Exp Dermatol 2001; 26:72-8.
13. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992; 40:1457-63.
14. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982; 61:310-6.
15. McKendrick MW, McGill JI, Wood MJ. Lack of effect of acyclovir on post-herpetic neuralgia. Br Med J 1989; 298:431.
16. McQuay HJ. Antidepressants and chronic pain. Effective analgesia in neuropathic pain and other syndromes. Br Med J 1997; 314:763-4.
17. Bean B, Braun C, Balfour HH. Acyclovir therapy for acute herpe zoster. Lancet 1982; 2:118-21.
18. Rabalais GP, Berkowitz FE, Hayward AR, Levin MJ. Inhibition of varicella-zoster virus in vitro by human peripheral blood mononuclear cells. Clin Exp Immunol 1989; 75:381-6.
19. Hayward AR, Cosyns M, Jones M et al. Cytokine production in varicella-zoster virus-stimulated cultures of human blood lymphocytes. J Infect Dis 1998; 178 (Suppl. 1):s95-8.
20. Wallace MR, Woelfl I, Bowler WA et al. Tumor necrosis factor, interleukin-2 and interferon-gamma in adult varicella. J Med Virol 1994; 43:69-71.
21. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000; 181:859-66.
22. Abendroth A, Arvin AM. Immune evasion as a pathogenic mechanism of varicella zoster virus. Sem Immunol 2001; 13:27-39.